Literature DB >> 22302975

A study of the pharmacodynamic interaction between befloxatone and ethanol on performance and mood in healthy volunteers.

J G Ramaekers1, N D Muntjewerff, M M Uiterwijk, L M van Veggel, A Patat, G Durrieu, J F O'Hanlon.   

Abstract

The effects of befloxatone (20 mg o.d. for 10 days) alone and in combination with ethanol on psychomotor performance, memory and mood were assessed in a randomized, double-blind, placebo controlled study. On treatment days 6, 8 and 10, subjects received 0.5 and 0.8 g/kg ethanol and ethanol placebo in randomly assigned, balanced orders, 2 h post-drug. Critical fusion frequency, choice reaction time, postural instability, critical tracking and mood were measured 1h before ethanol and 1, 3 and 5 h afterwards. Divided attention, sustained attention and memory (immediate and delayed recall) were also measured in single tests, 2.5-5 h post-ethanol.Ethanol's effects were generally significant when blood alcohol concentrations (BAC) after both doses were the highest; i.e. 0.48-0.67 and 0.96-1.10 mg/ml. Those effects were virtually gone after the subjects' mean BACs fell below 0.40 mg/ml. Befloxatone alone had no significant impairing effect in any test. Neither did it significantly interact with ethanol to cause any greater impairment than the latter alone. It was concluded that befloxatone does not potentiate the sedating and impairing effects of ethanol.

Entities:  

Year:  1996        PMID: 22302975     DOI: 10.1177/026988119601000405

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  2 in total

1.  Pharmacodynamic interactions of a solid formulation of sodium oxybate and ethanol in healthy volunteers.

Authors:  Nathalie Pross; Alain Patat; Philippe Vivet; Michelle Bidaut; Nicolas Fauchoux
Journal:  Br J Clin Pharmacol       Date:  2015-08-11       Impact factor: 4.335

Review 2.  Behavioural toxicity of medicinal drugs. Practical consequences, incidence, management and avoidance.

Authors:  J G Ramaekers
Journal:  Drug Saf       Date:  1998-03       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.